Clinical Trials
3 trialsNCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT01369953 2018-07-26
Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
National Institutes of Health Clinical Center (CC)
Completed
NCT01105923 2015-02-02
MAPLE
Brigham and Women's Hospital
Phase NA Unknown